Suma Ramadas, PhDMedical Affairs
Amy GilesIncreasing Engagement
Bud BilanichSuccess Coach
Daniel SontupeMarket Access
Matthew DurhamOmnidynamic Marketing
Joey CohenMedication Adherence
Stacey GandlerBrand Nourishment
Paul TheisenPatient Acquisition
Pat PurcellMeeting Engagement
Frank BurrellScientific Storytelling
Brenda SnowAuthentic Patient Voice
Liz KaneImpactful Strategy
Harshit Jain, MDProgrammatic Marketing
David LinetskyPoint-of-Care Marketing
Matt TurnerPatient Affordability
Tasigna is the first and only second-generation tyrosine kinase inhibitor approved in the EU ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email